mirum pharmaceutical

mirum pharmaceutical

NASDAQ:MIRM

Chart

Detailed Quote

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapies for debilitating liver diseases. It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Featured Articles and Interviews
male doctor wearing scrubs

Top 5 NASDAQ Genetics Stocks (Updated July 2022)

medical worker writing on clipboard

Top 5 NASDAQ Genetics Stocks (Updated April 2022)

Press Releases

Mirum Pharmaceuticals and Incyte Announce Positive Pivotal Phase 2 Results from PROGRESS Study of Zilurgisertib in Fibrodysplasia Ossificans Progressiva

Mirum Pharmaceuticals Announces New Data from Rare Liver Disease Programs Presented at the EASL International Liver Congress 2026

Mirum Pharmaceuticals to Present Data Showcasing Leadership in Rare Liver Diseases at the EASL International Liver Congress 2026

The Conversation (0)